Cargando…
Large-scale analyses of CAV1 and CAV2 suggest their expression is higher in post-mortem ALS brain tissue and affects survival
Introduction: Caveolin-1 and Caveolin-2 (CAV1 and CAV2) are proteins associated with intercellular neurotrophic signalling. There is converging evidence that CAV1 and CAV2 (CAV1/2) genes have a role in amyotrophic lateral sclerosis (ALS). Disease-associated variants have been identified within CAV1/...
Autores principales: | Adey, Brett N., Cooper-Knock, Johnathan, Al Khleifat, Ahmad, Fogh, Isabella, van Damme, Philip, Corcia, Philippe, Couratier, Philippe, Hardiman, Orla, McLaughlin, Russell, Gotkine, Marc, Drory, Vivian, Silani, Vincenzo, Ticozzi, Nicola, Veldink, Jan H., van den Berg, Leonard H., de Carvalho, Mamede, Pinto, Susana, Mora Pardina, Jesus S., Povedano Panades, Mónica, Andersen, Peter M., Weber, Markus, Başak, Nazli A., Shaw, Christopher E., Shaw, Pamela J., Morrison, Karen E., Landers, John E., Glass, Jonathan D., Vourc’h, Patrick, Dobson, Richard J. B., Breen, Gerome, Al-Chalabi, Ammar, Jones, Ashley R., Iacoangeli, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017967/ https://www.ncbi.nlm.nih.gov/pubmed/36937187 http://dx.doi.org/10.3389/fncel.2023.1112405 |
Ejemplares similares
-
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene
por: Cooper-Knock, Johnathan, et al.
Publicado: (2020) -
Rare variant burden analysis within enhancers identifies CAV1 as an ALS risk gene
por: Cooper-Knock, Johnathan, et al.
Publicado: (2021) -
The Effect of SMN Gene Dosage on ALS Risk and Disease Severity
por: Moisse, Matthieu, et al.
Publicado: (2021) -
Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023) -
Prognostic Value of CAV1 and CAV2 in Head and Neck Squamous Cell Carcinoma
por: He, Jingyu, et al.
Publicado: (2023)